Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524
NCT00192478
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
217
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus Infections
Interventions
BIOLOGICAL:
Medi-524
Sponsor
MedImmune LLC